Evidence map›Paper›PMID 41726057›Full record

ArticleJournal of the Society for Cardiovascular Angiography & Interventions2026

Impact of Anticoagulation on Valve Hemodynamics Following Transcatheter Valve-In-Valve Implantation.

Ankur Sethi, Emily Hiltner, John Tobia, Sara Henein, Jacinto Saenz, Tana LaPlaca, Casey Panebianco, Sabrena Butcher, Leonard Y Lee, Mark Russo

Abstract read
In one paragraph

Article in Journal of the Society for Cardiovascular Angiography & Interventions, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Ankur SethiValve Center, Division of Cardiology, Robert Wood Johnson University Hospital, New Brunswick, New Jersey.
Emily HiltnerValve Center, Division of Cardiology, Robert Wood Johnson University Hospital, New Brunswick, New Jersey.
John TobiaValve Center, Division of Cardiothoracic Surgery, Robert Wood Johnson University Hospital, New Brunswick, New Jersey.
Sara HeneinValve Center, Division of Cardiothoracic Surgery, Robert Wood Johnson University Hospital, New Brunswick, New Jersey.
Jacinto SaenzValve Center, Division of Cardiothoracic Surgery, Robert Wood Johnson University Hospital, New Brunswick, New Jersey.
Tana LaPlacaValve Center, Division of Cardiothoracic Surgery, Robert Wood Johnson University Hospital, New Brunswick, New Jersey.
Casey PanebiancoValve Center, Division of Cardiothoracic Surgery, Robert Wood Johnson University Hospital, New Brunswick, New Jersey.
Sabrena ButcherValve Center, Division of Cardiothoracic Surgery, Robert Wood Johnson University Hospital, New Brunswick, New Jersey.
Leonard Y LeeValve Center, Division of Cardiothoracic Surgery, Robert Wood Johnson University Hospital, New Brunswick, New Jersey.
Mark RussoValve Center, Division of Cardiothoracic Surgery, Robert Wood Johnson University Hospital, New Brunswick, New Jersey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Transcatheter aortic valve implantation (TAVI) for prosthetic valve dysfunction is frequently associated with suboptimal echocardiographic outcomes. The effect of anticoagulation on preserving valve function is not well understood. Methods: Patients who underwent the valve-in-valve TAVI for failed prosthetic aortic valves between 2015 and 2023 at a large academic medical center were retrospectively included. Data on anticoagulation use, along with clinical and echocardiographic outcomes, were collected. The end point of the study was the effect of anticoagulation use on the changes in mean gradient, peak velocity (V Results: One hundred thirteen patients (43 women) with a mean Society of Thoracic Surgeons score of 5.8 ± 5.5 were included in the study. Of these, 42% underwent valve fracture, and anticoagulation was used in 69.3% patients at discharge and 53.3% at 1-year follow-up. The mean gradient (β = 4.46, Conclusions: Anticoagulation postvalve-in-valve TAVI may lead to lower mean gradients and peak velocities at 1-year follow-up. More data are needed to understand its impact on nonflow-dependent indices and clinical outcomes.

Indexed as

anticoagulationgradientnon-vitamin K antagonist oral anticoagulantstranscatheter aortic valve implantationvalve-in-valve

Identifiers

PMID41726057
PMCPMC12923337

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.